XML 346 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated statement of changes in equity - USD ($)
$ in Millions
Total
Total
Share capital
Treasury shares
Share premium
Retained profits
 [3]
Other reserves
Non- controlling interests
Number of shares outstanding at beginning of period at Dec. 31, 2021     101,739,217 [1] 1,538,000        
Equity, beginning of period at Dec. 31, 2021 $ 2,740 $ 2,583 $ 153 [2] $ (60) $ 476 [2] $ 2,609 $ (594) [2] $ 157
Total comprehensive income/ (loss) for the year 155 204       177 27 [2] (49)
Effects of rights offering (in shares) [1],[2]     70,357,000          
Effects of rights offering [2] 717 717 $ 106   611      
Purchase of treasury shares [2] (2)             (2)
Purchase of treasury shares (in shares) [2]       (93,000)        
Purchase of treasury shares [2] (3) (3)   $ (4)   1    
Share based compensation [2] 26 25         25 1
Issuance of shares under share-based payment schemes (in shares)       419,000        
Issuance of shares under share-based payment schemes 1 1   $ 16 (2) [2] 4 (17) [2]  
Effect of the buy-out of non-controlling interests in Panama [4] 0 78       78   (78)
Number of shares, end of period (in shares) at Dec. 31, 2022     172,096,305 [1] 1,213,000        
Equity, end of period at Dec. 31, 2022 3,634 3,605 $ 258 [2] $ (47) 1,085 [2] 2,868 (559) [2] 29
Total comprehensive income/ (loss) for the year (223) (35)       (82) 47 [2] (188)
Transfer to legal reserve 0 [2] 0 [2]       (2) 2 [2]  
Purchase of treasury shares (in shares) [5]       (604,000)        
Purchase of treasury shares [5] (10) (10)   $ (18)   7    
Share based compensation [2] 52 50         50 1
Issuance of shares under share-based payment schemes (in shares)       1,447,000        
Issuance of shares under share-based payment schemes 1 1   $ 57 (9) [2] (7) (40) [2]  
Effect of the buy-out of non-controlling interests in Panama (1) (1)       (1)    
Put Option reserve [6] (81) (81)       (81)    
Capital injection in subsidiary [6] 74             74
Number of shares, end of period (in shares) at Dec. 31, 2023     172,096,000 [1] 370,000        
Equity, end of period at Dec. 31, 2023 3,445 3,529 $ 258 [2] $ (8) 1,076 [2] 2,703 (500) [2] (84)
Total comprehensive income/ (loss) for the year 280 250       253 (3) [2] 30
Dividends [7] (173) (172)       (172)   (1)
Transfer to legal reserve $ 0 0 [2]       (8) 8 [2]  
Purchase of treasury shares (in shares) (2,983,320)     (3,451,000) [5]        
Purchase of treasury shares [5] $ (72) (72)   $ (73)   1    
Share based compensation [2] 50 49         49 1
Share based cancellation (35) (35)         (35) [2]  
Issuance of shares under share-based payment schemes (in shares)       1,963,000        
Issuance of shares under share-based payment schemes 1 1   $ 38 (12) [2] 24 (50) [2]  
Put Option reserve [6] 79 79       79    
Number of shares, end of period (in shares) at Dec. 31, 2024     172,096,000 [1] 1,857,000        
Equity, end of period at Dec. 31, 2024 $ 3,574 $ 3,628 $ 258 [2] $ (43) $ 1,064 [2] $ 2,881 $ (531) [2] $ (54)
[1] The authorized share capital amounts to $300 million divided into 200 million shares with a par value of $1.50 each following the extraordinary general meeting held on February 28, 2022.
[2] Share capital, share premium (including the effects of rights offering) and other reserves (including share-based compensation) – see note C.1.
[3] Retained profits – includes profit for the year attributable to equity holders, of which $562 million (2023: $491 million; 2022: $472 million) are not distributable to equity holders.
[4] See note A.1.2..
[5] During the year ended December 31, 2024, Millicom repurchased 2,983,320 shares for a total amount of $63 million and withheld approximately 467,247 shares for the settlement of tax obligations on behalf of employees under share-based compensation plans (2023: 320,985; 2022: 93,413)
[6] See note C.7.4.
[7] On November 29, 2024, Millicom' Board has approved an interim dividend of $1.00 per share (or its equivalent in SEK per SDR) for approximately $172 million paid on January 10, 2025.